Gladstone’s Melanie Ott and Alex Marson Elected to the National Academy of Medicine
Physician-scientists and directors at Gladstone Institutes, Ott and Marson are honored for their pioneering achievements in science and medicine.
Roddenberry Stem Cell Center
Stem cells that have the potential to develop into any type of cell in the body are called pluripotent. Pluripotent stem cells arise naturally in the early stages of embryonic development. Induced pluripotent stem (iPS) cells are adult cells that have been reprogrammed to take on the properties of embryonic cells.
Scientists at Gladstone use iPS cells to better understand, prevent, treat, and cure some of the world’s most devastating diseases.
Gladstone strategically built a diverse community of scientific and clinical experts whose mission is to make groundbreaking scientific discoveries and bring these advances to the clinic. With expertise in stem cell biology, medicine, chemistry, and engineering, Gladstone is uniquely positioned to tackle complex problems from various angles with a highly collaborative, team-based approach.
The Roddenberry Stem Cell Center is an international powerhouse in stem cell research. Established in 2011 with a gift from the Roddenberry Foundation in honor of Eugene Roddenberry, the creator of Star Trek, the center operates with a vision of disrupting basic and translational stem cell science.
Scientific Areas of Focus
- Induced pluripotent stem cells
- Direct cellular reprogramming
- Reprogramming through chemical biology
- Modeling human disease
- Tissue engineering
The Roddenberry Stem Cell Center provides resources for the Gladstone community to pursue new biomedical discoveries and conduct the rigorous testing needed to translate their most promising findings to the clinic. IPS cells provide unparalleled insight into genetic diseases, empower personalized medicine, and may someday be used to generate tissues and organs for transplantation. The efforts of the Roddenberry Stem Cell Center help Gladstone scientists unlock this tremendous potential of stem cells to advance human health and transform the treatment of disease.
Disease Applications
- Amyotrophic lateral sclerosis (ALS)
- Alzheimer’s disease
- Cardiovascular disease
- Diabetes
- Huntington’s disease
- Liver failure
- Macular degeneration
- Parkinson’s disease
- Spinal cord injury
Support Discovery Science
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
DONATE NOWLatest News
Read
In Alzheimer’s Disease, the Brain’s Pacemaker Cells Lose Their Beat
Research in mice reveals how critical brain cells misfire in Alzheimer’s and identifies a targeted strategy to restore healthy brain rhythms.
Read
Gladstone Institutes Launches Redesigned Website, Bringing Cutting-Edge Biomedical Research Into Focus
Discover disease research, explore the latest scientific news, and connect with experts through Gladstone’s enriched digital platform.
Read
Newly Discovered Antiviral System in Bacteria Is ‘Strangest of Its Kind’
The complex Rube Goldberg-like molecular machinery could inspire novel technology to study and treat disease.
Read
Gladstone’s Seth Shipman Named Fellow of the California Academy of Sciences
Shipman is recognized for pioneering molecular technologies that record cellular activity, expand genome editing, and target antibiotic-resistant superbugs.
Get Involved
Join the Team
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsPartner With Us
Discoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreGive
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now